Occlusive coronary thrombosis and oral anticoagulants

Area of Science:

• Cardiovascular Medicine
• Clinical Pathology
• Pharmacology

Background:

• Myocardial infarction (MI) survivors face risks of reinfarction and cardiac complications.
• The role of oral anticoagulants in secondary prevention post-MI requires robust evidence.
• Understanding the relationship between anticoagulant therapy adequacy and coronary thrombotic events is crucial.

Purpose of the Study:

• To evaluate the impact of oral anticoagulant therapy on post-mortem findings in patients with prior myocardial infarction.
• To assess the frequency of recent occlusive coronary thromboses and recurrent MI in relation to anticoagulant treatment adequacy.

Main Methods:

• Post-mortem examination of 173 patients with a history of myocardial infarction, followed for an average of 5.5 years.
• Patients categorized into four groups based on oral anticoagulant use (adequate, inadequate, none).
• Quantification of coronary and myocardial lesions, with specific focus on recent occlusive coronary thromboses.

Main Results:

• Adequate anticoagulant therapy was associated with a fourfold reduction in recent occlusive coronary thromboses (p < 0.001).
• Recurrences of myocardial infarction were linked to recent occlusive thrombosis in 90% of cases.
• Effective long-term anticoagulant therapy reduced recurrent myocardial infarction frequency by fourfold (p < 0.001).

Conclusions:

• Effective long-term oral anticoagulant therapy is strongly associated with a significant decrease in coronary thrombosis and MI recurrence.
• Inadequate anticoagulant treatment offered no significant protective benefit compared to no treatment.
• These findings underscore the importance of adequate anticoagulation for secondary prevention in myocardial infarction patients.